Amneal Pharmaceuticals, Inc. provided earnings guidance for the full year of 2022. For the year, the company expects net revenue to be between $2.15 billion to $2.25 billion.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.535 USD | -1.73% | -2.67% | +8.24% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.24% | 2.05B | |
+39.65% | 723B | |
+34.28% | 595B | |
-4.12% | 369B | |
+20.34% | 332B | |
+2.83% | 282B | |
+17.02% | 244B | |
+9.31% | 208B | |
-5.07% | 205B | |
+0.10% | 168B |
- Stock Market
- Equities
- AMRX Stock
- News Amneal Pharmaceuticals, Inc.
- Amneal Pharmaceuticals, Inc. Provides Earnings Guidance for the Full Year of 2022